Zynerba Pharmaceuticals, Inc.

NASDAQ:ZYNE

1.3 (USD) • At close October 10, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Omzet 0000000000000000000.08600000000000.0070.0490.1990.0150.0150.0740.5250.0640.146
Kosten van de omzet 00000000000000000000000000000000000000
Brutowinst 0000000000000000000.08600000000000.0070.0490.1990.0150.0150.0740.5250.0640.146
Brutowinstmarge 00000000000000000010000000000111111111
Onderzoek- en ontwikkelingskosten 7.1677.0785.4685.0395.4465.1475.0226.3415.4524.6095.6165.80617.356.8837.458-1.6048.2246.3074.8764.868.5338.9765.8285.7545.7335.4914.9044.5044.8072.5693.3092.2721.0110.8540.8160.9330.3670.286
Algemene en administratieve kosten 3.9693.3933.2183.4543.7223.7573.8143.8694.3873.2764.5733.4264.4923.9173.9583.5313.2873.163.2563.1263.4363.4212.3762.7962.6332.2121.781.4931.4761.682.1561.9230.6310.6540.6632.1081.2060.1
Verkoop- en marketingkosten 00000000000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 3.9693.3933.2183.4543.7223.7573.8143.8694.3873.2764.5733.4264.4923.9173.9583.5313.2873.163.2563.1263.4363.4212.3762.7962.6332.2121.781.4931.4761.682.1561.9230.6310.6540.6632.1081.2060.1
Overige kosten 00000000000000000000000000000000000000
Bedrijfskosten 11.13610.4718.6868.4939.1698.9048.83610.2119.8387.88510.199.23221.84210.79911.4161.92611.5119.4668.1327.98611.9712.3968.2058.558.3667.7036.6855.9986.2844.2495.4654.1951.6421.5071.4783.041.5730.385
Bedrijfsresultaat -11.136-10.471-8.686-8.493-9.169-8.904-8.836-10.211-9.838-7.885-10.19-9.232-21.842-10.799-11.416-1.926-11.511-9.466-8.046-7.986-11.97-12.396-8.205-8.55-8.366-7.703-6.685-5.998-6.284-4.242-5.416-3.995-1.627-1.493-1.404-2.515-1.509-0.239
Bedrijfsresultaat ratio 000000000000000000-93.5610000000000-585.085-109.916-20.036-105.723-100.664-18.937-4.786-23.548-1.635
Totaal overige inkomsten en kosten netto -0.0750.3570.67-0.183-0.6840.3170.017-0.377-0.118-0.0820.5670.1721.483-1.740.406-0.457-0.063-0.032-0.066-0.1-0.224-0.085-0.070.076-0.0820.367-0.239-0.006-0.02-0.0230.0040.0020.0010.0010-0-0-0.001
Inkomen voor belasting -10.776-10.114-8.016-8.676-9.853-8.491-8.815-10.582-9.95-7.962-9.618-9.049-20.333-12.338-10.715-1.946-11.135-9.147-7.79-7.807-12.007-12.306-8.119-8.311-8.323-7.259-6.897-5.981-6.286-4.253-5.412-3.994-1.626-1.492-1.404-2.515-1.51-0.24
Inkomen voor belasting ratio 000000000000000000-90.5840000000000-586.571-109.827-20.028-105.677-100.618-18.937-4.787-23.553-1.643
Belastingkosten -0.36-0.357-0.3990.1830.684-0.413-0.0830.3720.1120.077-0.632-0.183-1.5091.538-0.7370.02-0.376-0.319-0.282-0.1780.037-0.09-0.112-0.238-0.042-0.4440.19-0.016-0.0560.0290.0280000000
Nettowinst -10.776-9.757-7.617-8.859-10.537-8.491-8.815-10.582-9.95-7.962-9.618-9.049-20.333-12.338-10.715-1.946-11.135-9.147-7.79-7.807-12.007-12.306-8.119-8.311-8.323-7.259-6.897-5.981-6.229-4.281-5.439-3.994-1.626-1.492-1.404-2.515-1.51-0.24
Nettowinstmarge 000000000000000000-90.5840000000000-590.534-110.386-20.028-105.677-100.618-18.937-4.787-23.553-1.643
WPA (Winst Per Aandeel) -0.21-0.2-0.17-0.2-0.25-0.21-0.22-0.26-0.25-0.2-0.33-0.31-0.78-0.53-0.46-0.084-0.5-0.47-0.44-0.47-0.89-0.91-0.6-0.63-0.64-0.6-0.71-0.67-0.7-0.49-0.59-0.66-0.19-0.26-0.24-0.44-0.26-0.042
Verwaterde WPA -0.21-0.2-0.17-0.2-0.25-0.21-0.22-0.26-0.25-0.2-0.33-0.31-0.78-0.53-0.46-0.084-0.5-0.47-0.44-0.47-0.89-0.91-0.6-0.63-0.64-0.6-0.71-0.67-0.7-0.49-0.59-0.66-0.19-0.26-0.24-0.44-0.26-0.042
EBITDA -10.996-10.33-8.949-8.007-8.339-9.16-8.853-9.772-9.659-7.741-10.756-9.346-23.276-9.018-11.822-1.433-11.415-9.406-7.981-7.861-11.724-12.284-8.134-8.601-8.26-8.05-6.446-5.965-6.249-4.205-5.403-3.987-1.624-1.491-1.403-2.508-1.5-0.23
EBITDA ratio 000000000000000000-92.7970000000000-580.022-109.647-19.995-105.522-100.567-18.918-4.773-23.406-1.569